Concentration tests 2017
| Components | Unit | Round 2017.1A | Round 2017.1B |
|---|---|---|---|
| Ethambutol | mg/l | 5,09 | |
| Levoflaxacin | mg/l | 10,1 | |
| Pyrazinamide | mg/l | 39,9 | |
| Moxifloxacin | mg/l | 5,30 | |
| Linezolid | mg/l | 10,3 | |
| Rifampicin | mg/l | 19,2 | |
| Isoniazide | mg/l | 10,12 | |
| acetyl-isoniazide | mg/l | 10,39 |
| Components | Unit | Round 2017.2A | Round 2017.2B |
|---|---|---|---|
| Ethambutol | mg/l | 1,02 | |
| Levoflaxacin | mg/l | 2,03 | |
| Pyrazinamide | mg/l | 7,97 | |
| Moxifloxacin | mg/l | 1,06 | |
| Linezolid | mg/l | 2,06 | |
| Rifampicin | mg/l | 3,85 | |
| Isoniazide | mg/l | 2,02 | |
| acetyl-isoniazide | mg/l | 2,08 |
Concentration tests 2016
| Components | Unit | Round 2016.1 A1 | Round 2016.1 A2 | Round 2016.1 B1 | Round 2016.1 B2 | Round 2016.1 C1 | Round 2016.1 C2 |
|---|---|---|---|---|---|---|---|
| Ethambutol | mg/l | 0.92 | 4.05 | ||||
| Isoniazid* | mg/l | 0.52 | 4.98 | ||||
| Levoflaxacin | mg/l | 1.96 | 14.98 | ||||
| Pyrazinamide | mg/l | 19.26 | 70.17 | ||||
| Moxifloxacin | mg/l | 0.40 | 3.21 | ||||
| Linezolid | mg/l | 1.81 | 13.02 | ||||
| Rifampicin | mg/l | 24.05 | 0.722 |
| Components | Unit | Round 2016.2 A1 | Round 2016.2 A2 | Round 2016.2 B1 | Round 2016.2 B2 | Round 2016.2 C1 | Round 2016.2 C2 |
|---|---|---|---|---|---|---|---|
| Ethambutol | mg/l | 2.40 | 7.31 | ||||
| Isoniazid* | mg/l | 1.54 | 4.93 | ||||
| Levoflaxacin | mg/l | 3.14 | 20.04 | ||||
| Pyrazinamide | mg/l | 29.53 | 64.44 | ||||
| Moxifloxacin | mg/l | 1.03 | 5.46 | ||||
| Linezolid | mg/l | 3.63 | 16.67 | ||||
| Rifampicin | mg/l | 9.62 | 2.41 |
* consensusvalues
Concentration tests 2015
| Components | Unit | Round 2015.1 | Round 2015.2 |
|---|---|---|---|
| Ethambutol | mg/l | 6,57 | 1,92 |
| Isoniazid | mg/l | 3,75 | 0,96 |
| Linezolid | mg/l | 13,97 | 1,40 |
| Moxifloxazin | mg/l | 3,19 | 0,41 |
| Pyrazinamide | mg/l | 75,93 | 14,15 |
| Rifampicin | mg/l | 6,43 | 2,19 |
| Desacetylrifampicin | mg/l | 6,47 | 2,07 |